Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines
Clinical trial NCT03216408 · COMPLETED
Trial details
- NCT number
- NCT03216408
- Sponsor
- Medy-Tox
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-30
- Primary completion
- 2016-11-10
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.